The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Press Commentary

28 Oct 2022 07:00

RNS Number : 4301E
Bidstack Group PLC
28 October 2022
 

28 October 2022

Bidstack Group Plc

("Bidstack" or the "Company" or the "Group")

Update re Press Commentary

Further to the Company's strategy update to the market on 26 October 2022, the Board notes recent press commentary regarding a private communication by the Company with certain investors concerning an email received from Azerion, which the Directors have been advised did not require disclosure under either the AIM Rules or MAR. In order to ensure that all shareholders have parity of information the Company wishes to give this update.

After the announcement on 5 October 2022 of the Group's Fundraise, Bidstack received an email from Azerion requesting certain information and reserving its rights under the Azerion agreement.

Given the nature of the Group's strong ongoing commercial relationship with Azerion and the extensive work taking place on the ground to ensure the success of the partnership by both Azerion and Bidstack, the Directors were surprised to receive this email.  At a commercial level, the Group's arrangements with Azerion continue to be operated on a 'business as usual' basis by both parties, with October already the highest grossing month to date and with November and December anticipated to grow further month on month. Bidstack has responded with detailed information demonstrating the Group's compliance with all areas identified. Bidstack has taken appropriate external legal advice and has concluded that Azerion has no present entitlement to end its agreement with the Group.

As referred to in the Company's announcement on 26 October 2022, following early evidence of its success in selling directly into North America and Japan, Bidstack intends to undertake a comprehensive business review, specifically reassessing and renegotiating, where appropriate, both existing and new reseller engagements in all geographies in order to maximise the benefits of its contacts with developers, publishers, ad-tech vendors and media companies.

Bidstack notes that Azerion is primarily a European-based group, with its sales-reach strongest in these territories. As announced on 20 September and 13 and 26 October, Bidstack has now invested in an experienced sales team with a proven track record in North America, which has a robust pipeline for FY23.

Bidstack's newly appointed Group Chief Revenue Officer is in active discussions on a number of significant global revenue opportunities, including additional resellers, licensors and media agreements, with anticipated contracts in FY23.

The Company would like to stress that, contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

The Directors also confirm that there are no discussions with Azerion regarding any offer for the Company.

The Board believes that the Company is trading in line with market expectations for the years ended 31 December 2022 and 2023.

-ENDS-

Contacts

Bidstack Group Plc

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

 

+44 (0) 203 368 3550

Stifel Nicolaus Europe Limited (Broker)

Fred Walsh / Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications Limited

Chris Lane / Stephanie Whitmore / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFEIILLTFIF
Date   Source Headline
27th Jul 20165:35 pmRNSHolding(s) in Company
25th Jul 20168:45 amRNSShare Option Schemes & Grant of Options
22nd Jul 20164:05 pmRNSResult of AGM & Result of General Meeting
21st Jul 20162:30 pmRNSFunding Update & Directors Participation
20th Jul 20165:15 pmRNSConditional Result of Open Offer
29th Jun 20169:45 amRNSNotice of 2016 Annual General Meeting and Posting
29th Jun 20167:01 amRNSProposed Fundraising and Loan Capitalisation
29th Jun 20167:00 amRNSBoard Changes
13th Jun 20167:10 amRNSFurther Working Capital Loan
13th Jun 20167:00 amRNSPreliminary Announcement of Results for 2015
8th Jun 20164:17 pmRNSHolding(s) in Company
22nd Mar 20167:00 amRNSSuccessful Customer Rollout With Strategic Partner
8th Feb 20167:00 amRNSLitigation Settlement
11th Jan 20167:00 amRNSAppointment of Non-Executive Director
30th Dec 20152:00 pmRNSTrading Update
23rd Dec 20151:00 pmRNSWorking Capital Raise
11th Dec 20154:15 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSBoard and Management Changes
23rd Nov 20157:00 amRNSLaunches Kiqplan Health & Fitness Training App
29th Oct 20157:00 amRNSHolding(s) in Company
19th Oct 20159:01 amRNSBoard Changes
30th Sep 20159:35 amRNSInterim Results
4th Sep 20152:30 pmRNSBoard Changes
27th Aug 20157:01 amRNSAppointment of CEO
10th Aug 20157:00 amRNS£1,665,000 Raised
18th Jun 20157:00 amRNSAgreement with Inflight Retail Specialist
16th Jun 20157:00 amRNSAppointment of Chief Financial Officer
1st Jun 20153:45 pmRNSResult of AGM
27th May 20157:00 amRNSDirectorate Change
12th May 20157:00 amRNSLaunch of four new Kiqplans and retail toolkits
8th May 20157:00 amRNSFinal Results
5th May 20157:01 amRNSPartnership with Tower Watson
29th Apr 20157:00 amRNSPartnership to Promote Employee-wellness
25th Feb 20157:00 amRNSAppeals Decision On Fitbit Trademark Infringement
24th Feb 20157:00 amRNSKiqplan available in Samsung's S Health globally
16th Feb 20157:00 amRNSStock Order by Leading US Midwesr Retailer
13th Feb 20157:00 amRNSTrading Update - H2 2014 Sales up 495%
29th Jan 201510:00 amRNSKiqplan Promotional Programme with Jawbone
27th Jan 20153:03 pmRNSUpdate re Legal Action Against Fitbit Inc
23rd Jan 20157:00 amRNSKiqplan: Partner of Cancer Research Race for Life
6th Jan 20157:00 amRNSAddition of New Functionality to Kiqplan
30th Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSNew Contracts with Amazon, Best Buy.com and Target
9th Dec 20147:00 amRNSGBP3.5 million Placing to Accelerate Growth
26th Nov 20147:00 amRNSLoan Extension
14th Nov 20147:00 amRNSKiqplan Partner Agreement with Samsung
7th Nov 20147:00 amRNSLaunch of KiQplan
5th Nov 20144:25 pmRNSBoard Changes
5th Nov 20144:23 pmRNSDirector's Dealings
28th Oct 20142:31 pmRNSFurther Statement re: Share Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.